The problems that should be noticed in choosing animal models with diabetic retinopathy

Chinese Journal of Ophthalmology

Volumn 48, Issue 7, 2012, Pages 587-590

  Wang, Ying Li ^a   Hui, Yan Nian ^b  

^a Meitan General Hospital   (China)

^b NONE

Author keywords

Choice behavior; Diabetic retinopathy; Disease models, animal

Indexed keywords

EID: 84867586740     PISSN: 04124081     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0412-4081.2012.07.005     Document Type: Article

References (22)

1. 2008, 44: 6-8.
2. 2010, 46: 97-99.
3. Du Z J, Kamei M, Suzuki M, et al. Coordinated expression of Ets-1, pERK1/2, and VEGF in retina of streptozotocin-induced diabetic rats. Ophthalmic Res, 2007, 39: 224-231.
4. Li Y J, Hui Y N, Yan F, et al. Up-regulation of integrin-linked kinase in the streptozotocin-induced diabetic rat retina. Graefes Arch Clin Exp Ophthalmol, 2007, 245: 1523-1532.
5. 2008, 44: 9-11.
6. Kador P F, Takahashi Y, Wyman M, et al. Diabeteslike proliferative retinal changes in galactose-fed dogs. Arch Ophthalmol, 1995, 113: 352-354.
7. Thompson C S. Animal models of diabetes mellitus: relevance to vascular complications. Curr Pharm Des, 2008, 14: 309-324.
8. Murata T, Nakagawa K, Khalil A, et al. The relation between expression of vascular endothelial growth factor and breakdown of the blood-retinal barrier in diabetic rat retinas. Lab Invest, 1996, 74: 819-825.
9. Hammes H P, Ali S S, Uhlmann M, et al. Aminoguanidine does not inhibit the initial phase of experimental diabetic retinopathy in rats. Diabetologia, 1995, 38: 269-273.
10. 2004, 40: 416-418.
11. Alvarez Y, Chen K, Reynolds A L, et al. Predominant cone photoreceptor dysfunction in a hyperglycaemic model of nonproliferative diabetic retinopathy. Dis Model Mech, 2010, 3: 236-245.
12. Kern T S, Tang J, Berkowitz B A. Validation of structural and functional lesions of diabetic retinopathy in mice. Mol Vis, 2010, 16: 2121-2131.
13. 2011, 47: 245-249.
14. Tso M O, Kurosawa A, Benhamou E, et al. Microangiopathic retinopathy in experimental diabetic monkeys. Trans Am Opththalmol Soc, 1988, 86: 389-421.
15. Buchi E R, Kurosawa A, Tso M O. Retinopathy in diabetic hypertensive monkeys: a pathologic study. Graefes Arch Clin Exp Ophthalmol, 1996, 234: 388-398.
16. Feit-Leichman R A, Kinouchi R, Takeda M, et al. Vascular damage in a mouse model of diabetic retinopathy: relation to neuronal and glial changes. Invest Ophthalmol Vis Sci, 2005, 46: 4281-4287.
17. Barber A J. A new view of diabetic retinopathy: a neurodegenerative disease of the eye. Prog Neuropsychopharmacol Biol Psychiatry, 2003, 27: 283-290.
18. Park S H, Park J W, Park S J, et al. Apoptotic death of photoreceptors in the streptozotocin-induced diabetic rat retina. Diabetologia, 2003, 46: 1260-1268.
19. Martin P M, Roon P, Van Ells T K, et al. Death of retinal neurons in streptozotocin-induced diabetic mice. Invest Ophthalmol Vis Sci, 2004, 45: 3330-3336.
20. Asnaghi V, Gerhardinger C, Hoehn T, et al. A role for the polyol pathway in the early neuroretinal apoptosis and glial changes induced by diabetes in the rat. Diabetes, 2003, 52: 506-511.
21. Plum L, Wunderlich F T , Baudler S, et al. Transgenic and knockout mice in diabetes research: novel insights into pathophysiology, limitations and perspective. Physiology (Bethesda), 2005, 20: 152-161.
22. LeRoith D, Gavrilova O. Mouse models created to study the pathophysiology of Type 2 diabetes. Int J Biochem Cell Biol, 2006, 38: 904-912.